The Generative AI Tracker notes that the healthcare generative artificial intelligence market is valued at more than $1 billion as of 2022, but technology companies and investors will play a significant role in development.
They’ll team up with healthcare companies including providers, payers and others in the healthcare ecosystem to train large language models on healthcare-specific data and establish robust benchmarks.
The Generative AI Tracker is a collaboration between Pymnts and Reno-based AI-ID, a platform that captures artificial intelligence outputs and manages authentication, source validation and data.
Their dive into the current state and future potential of generative AI in healthcare finds that, while most healthcare-focused companies and startups turning to generative AI for complex drug discovery, diagnostic testing and patient care challenges need to develop their solutions further, some are already reshaping care delivery and expanding research capabilities, Healthcare IT reports. Read more.
